AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 12 - (NewsRx.com & NewsRx.net) -- Medtronic, Inc., (MDT) announced the start of the U.S. pivotal clinical trial for the Intercept Epilepsy Control System, the company's brain-stimulation therapy that may reduce seizure rates in patients with epilepsy.
"Epilepsy remains a devastating disorder for one-third of patients who don't respond to medications, and brain stimulation may offer new hope for people with uncontrolled epilepsy," said Robert Fisher, MD, PhD, professor of neurology and director of Stanford Epilepsy Center, Stanford University, and principal investigator of the clinical trial. "Pilot studies have been encouraging and this clinical trial, if…
Source: HighBeam Research, Pivotal clinical trial for Intercept Epilepsy Control System begins.